We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors to Consider as Nu Skin (NUS) Gears Up for Q3 Earnings
Read MoreHide Full Article
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to display year-over-year declines in the top and bottom lines, when it reports third-quarter 2021 earnings on Nov 3. The Zacks Consensus Estimate for revenues is pegged at $682 million, suggesting a drop of 9.2% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for earnings has moved 19.1% south over the past 30 days to 93 cents per share, which indicates a decrease of 13.9% from the figure reported in the prior-year period. In the last reported quarter, the company delivered an earnings surprise of 8.5%. The developer and distributer of personal care and wellness products has a trailing four-quarter earnings surprise of 15.7%, on average.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Management, in a recent release, stated that the third-quarter revenues bore the brunt of challenges stemming from the disruptions caused by the delta variant across several markets. The unexpected government-imposed restrictions disrupted the sale and distribution of the company’s products, especially across the Mainland China and Southeast Asia regions. Nu Skin also encountered disturbances in its promotional activities, including the incentive trips and performance of local expos across various markets. The company lowered its third-quarter revenue guidance to a band of $637-$642 million compared with the earlier-anticipated range of $700-$730 million.
Nonetheless, management remained impressed with the launch of Collagen+ in the United States amid pandemic-inflicted disruptions. The company’s Tencent digital tools’ introduction across China, during the third quarter, bodes well. Apart from these, Nu Skin’s focus on empowering sales leaders via innovations and engaging technology platforms is noteworthy.
That said, rising selling as well as general and administrative expenses are a concern.
What the Zacks Model Unveils
Our proven model doesn’t conclusively predict an earnings beat for Nu Skin this time around. The combination of a positive Earnings ESP, and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Nu Skin currently carries a Zacks Rank #5 (Strong Sell) and has an Earnings ESP of -11.07%.
Stocks With Favorable Combinations
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season.
Image: Bigstock
Factors to Consider as Nu Skin (NUS) Gears Up for Q3 Earnings
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to display year-over-year declines in the top and bottom lines, when it reports third-quarter 2021 earnings on Nov 3. The Zacks Consensus Estimate for revenues is pegged at $682 million, suggesting a drop of 9.2% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for earnings has moved 19.1% south over the past 30 days to 93 cents per share, which indicates a decrease of 13.9% from the figure reported in the prior-year period. In the last reported quarter, the company delivered an earnings surprise of 8.5%. The developer and distributer of personal care and wellness products has a trailing four-quarter earnings surprise of 15.7%, on average.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. price-consensus-eps-surprise-chart | Nu Skin Enterprises, Inc. Quote
Key Factors to Note
Management, in a recent release, stated that the third-quarter revenues bore the brunt of challenges stemming from the disruptions caused by the delta variant across several markets. The unexpected government-imposed restrictions disrupted the sale and distribution of the company’s products, especially across the Mainland China and Southeast Asia regions. Nu Skin also encountered disturbances in its promotional activities, including the incentive trips and performance of local expos across various markets. The company lowered its third-quarter revenue guidance to a band of $637-$642 million compared with the earlier-anticipated range of $700-$730 million.
Nonetheless, management remained impressed with the launch of Collagen+ in the United States amid pandemic-inflicted disruptions. The company’s Tencent digital tools’ introduction across China, during the third quarter, bodes well. Apart from these, Nu Skin’s focus on empowering sales leaders via innovations and engaging technology platforms is noteworthy.
That said, rising selling as well as general and administrative expenses are a concern.
What the Zacks Model Unveils
Our proven model doesn’t conclusively predict an earnings beat for Nu Skin this time around. The combination of a positive Earnings ESP, and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Nu Skin currently carries a Zacks Rank #5 (Strong Sell) and has an Earnings ESP of -11.07%.
Stocks With Favorable Combinations
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season.
Tyson Foods (TSN - Free Report) has an Earnings ESP of +19.13% and carries a Zacks Rank #3, at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Coty Inc. (COTY - Free Report) has an Earnings ESP of +50.00% and carries a Zacks Rank of 3, currently.
The Estee Lauder Companies (EL - Free Report) has an Earnings ESP of +0.24% and currently holds a Zacks Rank #3.